To investigate the population pharmacokinetics (PK) and pharmacodynamics (PD) of bivalirudin, a synthetic bivalent direct thrombin inhibitor, in young healthy Chinese subjects. Thirty-six young ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback